85 related articles for article (PubMed ID: 16621190)
1. Transcutaneous vaccination with virus-like particles.
Young SL; Wilson M; Wilson S; Beagley KW; Ward V; Baird MA
Vaccine; 2006 Jun; 24(26):5406-12. PubMed ID: 16621190
[TBL] [Abstract][Full Text] [Related]
2. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
Bessa J; Schmitz N; Hinton HJ; Schwarz K; Jegerlehner A; Bachmann MF
Eur J Immunol; 2008 Jan; 38(1):114-26. PubMed ID: 18081037
[TBL] [Abstract][Full Text] [Related]
3. The recombinant rabbit hemorrhagic disease virus VP60 protein obtained from Pichia pastoris induces a strong humoral and cell-mediated immune response following intranasal immunization in mice.
Farnós O; Rodríguez M; Chiong M; Parra F; Boué O; Lorenzo N; Colás M; Lleonart R
Vet Microbiol; 2006 May; 114(3-4):187-95. PubMed ID: 16384666
[TBL] [Abstract][Full Text] [Related]
4. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge.
Chung YC; Ho MS; Wu JC; Chen WJ; Huang JH; Chou ST; Hu YC
Vaccine; 2008 Mar; 26(15):1855-62. PubMed ID: 18329759
[TBL] [Abstract][Full Text] [Related]
5. Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation.
Peacey M; Wilson S; Baird MA; Ward VK
Biotechnol Bioeng; 2007 Dec; 98(5):968-77. PubMed ID: 17546687
[TBL] [Abstract][Full Text] [Related]
6. Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.
Lenz P; Lowy DR; Schiller JT
Eur J Immunol; 2005 May; 35(5):1548-56. PubMed ID: 15832296
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants.
Revaz V; Zurbriggen R; Moser C; Schiller JT; Ponci F; Bobst M; Nardelli-Haefliger D
Antiviral Res; 2007 Oct; 76(1):75-85. PubMed ID: 17617476
[TBL] [Abstract][Full Text] [Related]
8. Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG.
Song S; Wang Y; Zhang Y; Wang F; He Y; Ren D; Guo Y; Sun S
Cancer Lett; 2007 Oct; 256(1):90-100. PubMed ID: 17656012
[TBL] [Abstract][Full Text] [Related]
9. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.
Linghua Z; Xingshan T; Fengzhen Z
Vaccine; 2008 Jan; 26(2):224-33. PubMed ID: 18063448
[TBL] [Abstract][Full Text] [Related]
10. Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cells.
Fausch SC; Da Silva DM; Kast WM
Vaccine; 2005 Feb; 23(14):1720-9. PubMed ID: 15705478
[TBL] [Abstract][Full Text] [Related]
11. Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant.
Crisci E; Almanza H; Mena I; Córdoba L; Gómez-Casado E; Castón JR; Fraile L; Bárcena J; Montoya M
Virology; 2009 May; 387(2):303-12. PubMed ID: 19327809
[TBL] [Abstract][Full Text] [Related]
12. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
[TBL] [Abstract][Full Text] [Related]
13. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.
Zhang YL; Guo YJ; Wang KY; Lu K; Li K; Zhu Y; Sun SH
Scand J Immunol; 2007 Apr; 65(4):320-8. PubMed ID: 17386022
[TBL] [Abstract][Full Text] [Related]
14. Virus-like particles and α-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responses.
McKee SJ; Young VL; Clow F; Hayman CM; Baird MA; Hermans IF; Young SL; Ward VK
J Control Release; 2012 May; 159(3):338-45. PubMed ID: 22386518
[TBL] [Abstract][Full Text] [Related]
15. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice.
Song X; Bao S; Wu L; Hu S
Vaccine; 2009 Jan; 27(1):51-5. PubMed ID: 18973783
[TBL] [Abstract][Full Text] [Related]
16. Antigen incorporated in virus-like particles is delivered to specific dendritic cell subsets that induce an effective antitumor immune response in vivo.
Li K; Peers-Adams A; Win SJ; Scullion S; Wilson M; Young VL; Jennings P; Ward VK; Baird MA; Young SL
J Immunother; 2013 Jan; 36(1):11-9. PubMed ID: 23211625
[TBL] [Abstract][Full Text] [Related]
17. A recombinant adenovirus prime-virus-like particle boost regimen elicits effective and specific immunities against norovirus in mice.
Guo L; Zhou H; Wang M; Song J; Han B; Shu Y; Ren L; Si H; Qu J; Zhao Z; Wang J; Hung T
Vaccine; 2009 Aug; 27(38):5233-8. PubMed ID: 19589399
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
19. Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response.
Peacey M; Wilson S; Perret R; Ronchese F; Ward VK; Young V; Young SL; Baird MA
Vaccine; 2008 Oct; 26(42):5334-7. PubMed ID: 18706958
[TBL] [Abstract][Full Text] [Related]
20. Recombinant VP60 in the form of virion-like particles as a potential vaccine against rabbit hemorrhagic disease virus.
Gromadzka B; Szewczyk B; Konopa G; Fitzner A; Kesy A
Acta Biochim Pol; 2006; 53(2):371-6. PubMed ID: 16733562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]